Steven Ledger - Sep 9, 2024 Form 4 Insider Report for Serina Therapeutics, Inc. (SER)

Role
Chief Executive Officer, Director
Signature
/s/ Steven Ledger
Stock symbol
SER
Transactions as of
Sep 9, 2024
Transactions value $
$0
Form type
4
Date filed
9/11/2024, 04:30 PM
Previous filing
Apr 3, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SER Stock Option (right to buy) Award $0 +376K +330.28% $0.00 490K Sep 9, 2024 Common Stock 376K $7.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vest as to 12.5% of the underlying shares on March 9, 2025 and thereafter in substantially equal monthly installments such that the stock options shall be fully vested on the fourth anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.